Markets:

Overview

News

Currencies

International

Treasuries

Biogen Idec (NQ:BIIB)

196.52 +1.02 (+0.52%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Biogen Idec

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

48 49 Next >

How Many Stocks Are Down From Their Pre-COVID Levels? ↗

February 21, 2022

On February 19th, 2020, the S&P 500 made its last closing high prior to all hell breaking loose for the next month.

Via Talk Markets

Why A Biogen-Sage Drug Flopped — And Could Still Be Approved ↗

February 16, 2022

The companies tested a combination of zuranolone and depression drugs.

Via Investor's Business Daily

Sage Therapeutics - Biogen Partnered Depression Drug Meets Main Goal In Late-stage Study ↗

February 16, 2022

Sage Therapeutics Inc (NASDAQ: SAGE) and Biogen Inc (NASDAQ: BIIB) said zuranolone combined with a standard of care antidepressant met the primary goal of showing...

Via Benzinga

US Senate Narrowly Votes In Favor Of Biden's Nominee Robert Califf To Lead FDA For Second Time ↗

February 16, 2022

By a narrow vote of 50-46, the Senate has confirmed Robert Califf to run the FDA. Califf, who previously served as the FDA commissioner from February 2016 to January...

Via Benzinga

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa ↗

February 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following...

Via Benzinga

What 24 Analyst Ratings Have To Say About Biogen ↗

February 04, 2022

Within the last quarter, Biogen (NASDAQ:BIIB) has observed the following analyst ratings:

Via Benzinga

Analyst Ratings For Biogen ↗

February 04, 2022

Analysts have provided the following ratings for Biogen (NASDAQ:BIIB) within the last quarter:

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

February 17, 2022

On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company...

Via Benzinga

Revisiting the Biggest Winners and Losers Since the COVID Crash Low ↗

February 16, 2022

A look at how the average stock that’s currently in the S&P 1500 has done since the Covid crash low by sector.

Via Talk Markets

Large Cap Biopharma- Well Positioned For Choppy Markets ↗

February 14, 2022

If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets.

Via Talk Markets

Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane ↗

February 08, 2022

Biogen Inc (NASDAQ: BIIB) and Xbrane Biopharma AB have

Via Benzinga

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar ↗

February 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Biogen: Q4 Earnings Insights ↗

February 03, 2022

Biogen (NASDAQ:BIIB) reported its Q4 earnings results on Thursday, February 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Biogen's Alzheimer's Struggles Continue; 'Minimal' Sales Expected This Year ↗

February 03, 2022

Biogen's new Alzheimer's drug generated $1 million in fourth-quarter sales.

Via Investor's Business Daily

Recap: Biogen Q4 Earnings ↗

February 03, 2022

Biogen (NASDAQ:BIIB) reported its Q4 earnings results on Thursday, February 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

February 07, 2022

BMO Capital cut the price target for Match Group, Inc. (NASDAQ: MTCH) from $150 to $130. Match Group shares fell 1.4% to trade at $114.33 on Monday.

Via Benzinga

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, & More ↗

February 06, 2022

Biotech stocks managed to close the week with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid some big pharma earnings. The sector came...

Via Talk Markets

Biogen's Aduhelm Approval, Marketing Comes Under FTC, SEC Probes ↗

February 04, 2022

The Federal Trade Commission (FTC) and the Securities and Exchange Commission (SEC) have launched two separate investigations into Biogen Inc (NASDAQ: BIIB) and its Alzheimer's med, Aduhelm...

Via Benzinga

Stock Market Rally Volatile; Google, Facebook, Amazon, Snap Are Earnings Movers: Weekly Review ↗

February 04, 2022

The major indexes slashed weekly gains after Monday's follow-through day.

Via Investor's Business Daily

Earnings Scheduled For February 3, 2022 ↗

February 03, 2022

Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter.

Via Benzinga

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2022 ↗

February 04, 2022

Upgrades CBRE upgraded the previous rating for Penn National Gaming Inc (NASDAQ:PENN) from Hold to Buy. For the fourth quarter, Penn National Gaming had an EPS of $0.26,...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

February 04, 2022

JP Morgan boosted the price target for Amazon.com, Inc. (NASDAQ: AMZN) from $4,350 to $4,500. Amazon shares jumped 11% to $3,081.07 in pre-market trading.

Via Benzinga

Facebook FB plunges but Amazon AMZN surges: Earnings and Your Updated Price Levels ↗

February 03, 2022

It seems like yesterday we were discussing the surge in Alphabet shares, and today we're focusing on big moves - currently in opposite directions - of Facebook and Amazon, all major market cap...

Via Talk Markets

Biogen's Alzheimer's Drug Clocks Q4 Sales Of Just $1M, FY22 Earnings Guidance Below Consensus ↗

February 03, 2022

Biogen Inc (NASDAQ: BIIB) posted Q4 sales of 2.73 billion, beating the consensus of $

Via Benzinga

The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation ↗

February 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

February 03, 2022

On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on...

Via Benzinga

Earnings Preview For Biogen ↗

February 02, 2022

Biogen (NASDAQ:BIIB) is set to give its latest quarterly earnings report on Thursday, 2022-02-03. Here's what investors need to know before the announcement. Analysts estimate that Biogen will likely...

Via Benzinga

World Markets News for Tuesday ↗

February 01, 2022

Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon.

Via Talk Markets

Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab ↗

February 01, 2022

Biogen Inc (NASDAQ: BIIB) has

Via Benzinga

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

48 49 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Biogen Idec (NQ:BIIB)

Headline News about Biogen Idec

Starting at $3.75/week.

Subscribe Today